Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Added:
3 years ago
People with human immunodeficiency virus (HIV) are more prone to sudden cardiac death (SCD) than the general population, say researchers.
The team found that HIV-infected patients suffered SCD at a rate more than four times higher than that expected in the general population with similar risk factors.
“As part of my ongoing research in 2010, we were looking at every instance of sudden death in…
View more
Added:
3 years ago
WEARABLE CARDIOVERTER DEFIBRILLATORS PROVE TO BE SAFE FOR PEDIATRIC PATIENTS AT RISK FOR SUDDEN CARDIAC ARREST
Largest study of its kind finds device effective in detecting
and treating life-threatening arrhythmias
CHICAGO, May 11, 2017 – A new study shows that the use of a wearable cardioverter defibrillator (WCD) is safe and effective in treating ventricular arrhythmias for pediatric patients…
View more
Author(s):
José González-Costello
Added:
10 months ago
According to Dr José González-Costello (Hospital Universitario de Bellvitge, ES) ESC guideline-directed sudden cardiac death (SCD) risk stratification in patients with newly diagnosed HF is crucial for identifying individuals at high risk of SCD and implementing appropriate preventive strategies. By adhering to ESC guidelines and incorporating patient-specific modalities, clinicians can…
View more
Author(s):
Perry Elliott
Added:
1 year ago
In this two-part hypertrophic cardiomyopathy (HCM) video series, Prof Perry Elliott discussesstratifying sudden cardiac death (SCD) risk in HCM patients and how to select treatment (ICD vs no ICD), including approach in primary prevention and secondary patients.
View more
Added:
3 years ago
Physicians rate patient preferences lower than mortality benefit in the decision to place implantable cardioverter-defibrillators (ICDs), show results of a web-based survey of physicians.
“Despite the increasing focus on shared decision making and patient-centered care, over half of the respondents in this survey rated patient preferences lower than expected mortality benefits,” say the study…
View more
Added:
3 years ago
Source:
ZOLL LifeVest
August 26, 2016—CHELMSFORD, MASS.—ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced that results from the largest German registry of patients prescribed the LifeVest® Wearable Defibrillator reaffirm that the LifeVest is a safe and effective therapy for the prevention of sudden cardiac death (SCD) in the German…
View more
Author(s):
Hillel A Steiner
,
Yonathan Hasin
Added:
3 years ago
Sudden cardiac death (SCD) remains a public health problem of immense magnitude, afflicting an estimated 300,000 persons per year in the US.1 SCD, defined as death occurring within one hour from symptom-onset, is associated with ischemic heart disease in 80% of cases. Approximately one-third of cases are the result of an acute occlusion of an epicardial coronary artery.2 Some 50% of the mortality…
View more
Author(s):
David Calvo Cuervo
Added:
1 year ago
Author(s):
Vincent Floré
,
Rik Willems
Added:
3 years ago
Sudden cardiac arrest (SCA) can be defined as the abrupt cessation of cardiac activity due to an underlying cardiac cause, occurring instantaneously in a previously stable patient and in the absence of non-cardiovascular causes (e.g., trauma, intoxication, drowning, electrocution).1,2 SCA will lead to loss of consciousness within the minute due to insufficient cerebral perfusion. If no immediate…
View more